Valuation: Haleon plc

Market Cap 32.47B 43.65B 37.91B 35.21B 61.16B 4,167B 62.27B 417B 163B 2,070B 164B 160B 6,960B P/E 2026 *
18.8x
P/E 2027 * 17x
Enterprise Value 39.33B 52.88B 45.93B 42.65B 74.09B 5,048B 75.43B 505B 198B 2,507B 199B 194B 8,431B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.27x
Free-Float
99.42%
Yield 2026 *
2.15%
Yield 2027 * 2.42%
1 day-2.92%
1 week+1.94%
Current month+6.01%
1 month+6.01%
3 months+8.41%
6 months-2.72%
Current year-1.65%
1 week 365.7
Extreme 365.7
384.2
1 month 351.83
Extreme 351.828
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.92%+1.94%+1.01%+9.38% 43.65B
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
-2.29%+1.12%+36.13%+31.18% 350B
-2.28%-0.69%+33.42%+40.48% 299B
-3.15%+0.25%+10.63%+15.03% 265B
-2.12%+3.31%+1.82%-37.38% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -1.94%+4.73%+26.69%+46.27% 365.63B
Weighted average by Cap. -1.65%+4.86%+37.40%+71.44%

Financials

2026 *2027 *
Net sales 11.4B 15.32B 13.31B 12.36B 21.47B 1,463B 21.86B 146B 57.29B 727B 57.54B 56.28B 2,443B 11.88B 15.98B 13.88B 12.89B 22.39B 1,525B 22.79B 153B 59.73B 757B 59.99B 58.68B 2,547B
Net income 1.71B 2.3B 1.99B 1.85B 3.22B 219B 3.27B 21.92B 8.58B 109B 8.62B 8.43B 366B 1.92B 2.58B 2.24B 2.08B 3.61B 246B 3.68B 24.6B 9.63B 122B 9.68B 9.46B 411B
Net Debt 6.86B 9.23B 8.01B 7.44B 12.93B 881B 13.16B 88.1B 34.5B 437B 34.65B 33.89B 1,471B 6.39B 8.59B 7.46B 6.93B 12.04B 820B 12.26B 82.05B 32.13B 407B 32.27B 31.56B 1,370B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-30 GBX 368.60 -2.92% 27,282,182
26-07-29 GBX 379.70 -0.32% 36,335,259
26-07-28 GBX 380.90 +2.89% 29,790,922
26-07-27 GBX 370.20 +1.84% 24,375,691
26-07-24 GBX 363.50 +0.53% 12,865,658
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.686GBP
Average target price
4.157GBP
Spread / Average Target
+12.78%

Quarterly revenue - Rate of surprise